CAD and cancer: To determine whether CPS genes sequencing among all children with cancer can serve as a replacement or add-on test, the diagnostic yield, as well as other relevant aspects, such as costs and the number of unsolicited findings, should be compared with that of the classical phenotype-driven diagnostic approach.